DE-ESCALATION STRATEGIES IN BREAST CANCER CARE MANAGEMENT

BSI / AWS

Christine Laronga Moderator United States

Panel discussion on how the management of breast cancer and breast diseases is de-escalating without impacting survival - Global variations. [each panelist will have 10 minutes to discuss their assigned topic followed by case scenarios from moderators to have panelists answer from their countries perspective].

Time	Session

10:30 10:48	TARGETED AXILLARY DISSECTION (FOLLOWING NEOADJUVANT SYSTEMIC THERAPY FOR (HER2+ OR TNBC) OR UPFRONT SURGERY IN HORMONE RECEPTOR POSITIVE) FOR CN1 DISEASE 223-1 KandaceMcGuire Speaker United States Molino Rey B
10:48 11:06	OMISSION OF RADIATION POST BREAST CONSERVING SURGERY 223-2 NereidaEsparza Arias Speaker Mexico Molino Rey B
11:06 11:24	OMISSION OF SENTINEL LYMPH NODE BIOPSY FOR INVASIVE BREAST CANCER (SOUND, NAUTILUS, SOAPET, BOOG 2013-08, INSEMA) 223-3 HelenJohnson Speaker United States Molino Rey B
11:24 11:42	ACTIVE SURVEILLANCE FOR DCIS (COMET TRIAL, LORD, LORIS) 223-4 E. ShelleyHwang Speaker United States Molino Rey B
11:42 12:00	OMISSION OF BREAST SURGERY IN EARLY BREAST CANCER 223-5 Molino Rey B

International Society of Surgery (ISS)

Société Internationale de Chirurgie (SIC)

DE-ESCALATION STRATEGIES IN BREAST CANCER CARE MANAGEMENT